Indian Drug Makers Slow To Join Consolidation Bandwagon

While drug makers in other countries engage in mergers and acquisitions, their Indian colleagues see consolidation as a few years away. Although the movement may be slower, consolidation is expected in India as firms led by their entrepreneurs become vulnerable to such a move. But one industry official said that just one successful deal could spark more. A company is seen vulnerable if its promoter holds less than a majority interest. (Click here for more